Treatment of spasticity with botulinum toxin A;Behandling av spastisitet med botulinumtoksin

Tidsskrift for den Norske Laegeforening

Volumn 117, Issue 14, 1997, Pages 2022-2024

  Kerty, Emilia ^a   Stien, Ragnar ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Neurologisk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PROMETHAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MULTIPLE SCLEROSIS; SPASTICITY;

ADULT; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY;

EID: 0030740978     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Kerty E, Gjerstad L, Nyberg-Hansen R. Botulinumtoksinbehandling av spastisk torticollis. Tidsskr Nor Lægeforen 1992; 112: 2660-2.
2. Ringstad Ø, Kerty E. Hemifaciale spasmer. Årsaker, klinikk og behandling. Tidsskr Nor Lægeforen 1995; 115: 2777-9.
3. Loven J-Ø, Brondbo K, Ganes T. Botulinumtoksin. Et nytt behandlingsalternativ ved spastisk dysfoni (laryngeal adduktordystoni). Tidsskr Nor Lægeforen 1993; 113: 841-3.
4. Amthor K-F, Skjelland M, Heier MS. Behandling av skrivekrampe med botulinumtoksin. Tidsskr Nor Lægeforen 1994; 114: 1830-1.
5. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964; 192: 540-2.
6. Snow BJ, Tsui JKC, Bhatt MH, Varelas M, Hashimoto SA, Calne DB. Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1990; 28: 512-5.
7. Haller P, Jurow C. Botulinum toxin treatment in patients with multiple sclerosis. Mov Dis 1995; 10: 379.
8. Stien R, Nordal HJ, Ofledal SI, Slettebø M. The treatment of spasticity in multiple sclerosis: a double-blind clinical study of a new anti-spastic drug tizanidine compared with baclofen. Acta Neurol Scand 1987; 75: 190-4.
9. Garland DE, Lucie RS, Walters RL. Current uses of open phenol nerve block for adult acquired spasticity. Clin Orthop 1982; 166: 217-22.
10. Penn RD, Savoy SM, Corcos DM, Latash M, Gottlieb G, Parke B et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989; 320: 1517-21.
11. Hesse S, Lücke D, Malezic M, Bertelt C, Friedrich H, Gregoric M et al. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 1994; 57: 1321-4.
12. Yablon SA. Botulinum toxin A: experience in the management of spasticity among patients with traumatic brain injury. European Journal of Neurology 1995; 2: 47-55.
13. Cosgrove AP, Graham HK. Botulinum A prevents the development of contractures in the hereditary spastic mouse. Dev Med Child Neurol 1984; 36: 379-85.